TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Taubert medicin AB
Closing information (x1000 DKK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
1,180
|
694
|
146 |
Financial expenses |
1
![]() |
1
|
0 |
Earnings before taxes |
82
|
22
|
-53 |
EBITDA |
82
|
22
|
-53 |
Total assets |
267
|
193
|
93 |
Current assets |
267
|
193
|
93 |
Current liabilities |
159
|
140
|
71 |
Equity capital |
105
|
41
|
22 |
- share capital |
32
|
33
|
36 |
Employees (average) |
2
![]() |
2
|
1 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
39.3%
|
21.2%
|
23.7% |
Turnover per employee |
590
|
347
|
146 |
Profit as a percentage of turnover |
6.9%
|
3.2%
|
-36.3% |
Return on assets (ROA) |
31.1%
|
11.9%
|
-57.0% |
Current ratio |
167.9%
|
137.9%
|
131.0% |
Return on equity (ROE) |
78.1%
|
53.7%
|
-240.9% |
Change turnover |
510
|
561
|
-51 |
Change turnover % |
76%
|
422%
|
-26% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
100% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.